U.S. Senator Richard Blumenthal of Connecticut wants the FDA to address the price of EpiPens, the auto-injected medication used to stop severe allergic reactions.
EpiPen prices have gone up sharply since a nationwide shortage started last year. In Connecticut, generic versions of EpiPen cost nearly $400. Name-brand EpiPens can run more than $700.
Blumenthal says that makes EpiPens a major financial burden for families and schools.
“That is a national scandal. The shortages, the astronomic rise in prices are a national disgrace.”
Mylan, the company that makes EpiPens, blames problems on manufacturing delays.
Blumenthal said the company should reduce its prices and eliminate the delays. He also called on the FDA to approve more generic versions of EpiPen.